Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]

J Alfred Witjes¹, Harman Max Bruins², Albert Carrión³, Richard Cathomas⁴, Eva Compérat⁵, Jason A Efstathiou⁶, Rainer Fietkau⁷, Georgios Gakis⁸, Anja Lorch⁹, Alberto Martini¹⁰, Laura S Mertens¹¹, Richard P Meijer¹², Matthew I Milowsky¹³, Yann Neuzillet¹⁴, Valeria Panebiaco¹⁵, John Redlef¹⁶, Michael Rink¹⁷, Mathieu Rouanne¹⁴, George N Thalmann¹⁸, Sæbjørn Sæbjørnsen¹⁶, Erik Veskimäe¹⁹, Paramananthan Mariappan²⁰, Antoine G van der Heijden²¹

Affiliations

¹ Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: fred.witjes@radboudumc.nl.
² Department of Urology, Zuyderland Medisch Centrum, Sittard/Heerlen, The Netherlands.
³ Department of Urology, Vall Hebron Hospital, Autonomous University of Barcelona, Barcelona, Spain.
⁴ Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland.
⁵ Department of Pathology, Medical University Vienna General Hospital, Vienna, Austria.
⁶ Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
⁷ Department of Radiation Therapy, University of Erlangen, Erlangen, Germany.
⁸ Department of Urology and Pediatric Urology, University of Würzburg, Würzburg, Germany.
⁹ Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
¹⁰ Department of Urology, Institut Universitaire du Cancer-Toulouse-Oncopole, Toulouse, France; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
¹¹ Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹² Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
¹³ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
¹⁴ Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.
¹⁵ Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy.
¹⁶ Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands.
¹⁷ Department of Urology, Marienkrankenhaus Hamburg, Hamburg, Germany.
¹⁸ Department of Urology, Inselspital, University Hospital Bern, Bern, Switzerland.
¹⁹ Department of Urology, Tampere University Hospital, Tampere, Finland.
²⁰ Edinburgh Bladder Cancer Surgery (EBCS), Western General Hospital, University of Edinburgh, Edinburgh, The United Kingdom.
²¹ Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

PMID: 38492977
DOI: 10.1016/j.eururo.2024.03.002

Published Erratum

Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]

J Alfred Witjes et al. Eur Urol. 2024 Jun.

. 2024 Jun;85(6):e180.

doi: 10.1016/j.eururo.2024.03.002. Epub 2024 Mar 15.

Authors

Affiliations

¹ Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: fred.witjes@radboudumc.nl.
² Department of Urology, Zuyderland Medisch Centrum, Sittard/Heerlen, The Netherlands.
³ Department of Urology, Vall Hebron Hospital, Autonomous University of Barcelona, Barcelona, Spain.
⁴ Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland.
⁵ Department of Pathology, Medical University Vienna General Hospital, Vienna, Austria.
⁶ Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
⁷ Department of Radiation Therapy, University of Erlangen, Erlangen, Germany.
⁸ Department of Urology and Pediatric Urology, University of Würzburg, Würzburg, Germany.
⁹ Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
¹⁰ Department of Urology, Institut Universitaire du Cancer-Toulouse-Oncopole, Toulouse, France; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
¹¹ Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹² Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
¹³ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
¹⁴ Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.
¹⁵ Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy.
¹⁶ Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands.
¹⁷ Department of Urology, Marienkrankenhaus Hamburg, Hamburg, Germany.
¹⁸ Department of Urology, Inselspital, University Hospital Bern, Bern, Switzerland.
¹⁹ Department of Urology, Tampere University Hospital, Tampere, Finland.
²⁰ Edinburgh Bladder Cancer Surgery (EBCS), Western General Hospital, University of Edinburgh, Edinburgh, The United Kingdom.
²¹ Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

PMID: 38492977
DOI: 10.1016/j.eururo.2024.03.002

No abstract available

PubMed Disclaimer

Erratum for

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, Mertens LS, Meijer RP, Milowsky MI, Neuzillet Y, Panebianco V, Redlef J, Rink M, Rouanne M, Thalmann GN, Sæbjørnsen S, Veskimäe E, van der Heijden AG. Alfred Witjes J, et al. Eur Urol. 2024 Jan;85(1):17-31. doi: 10.1016/j.eururo.2023.08.016. Epub 2023 Oct 17. Eur Urol. 2024. PMID: 37858453 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]

Affiliations

Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources